Related Experiment Video

Updated: Jun 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Bowel management for the treatment of pediatric fecal incontinence

Andrea Bischoff1, Marc A Levitt, Alberto Peña

  • 1Colorectal Center for Children, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, ML 2023, Cincinnati, OH 45229, USA.

Pediatric Surgery International
|October 16, 2009
PubMed

Insights

Fecal incontinence in children can be effectively managed with a specialized bowel program. This 30-year study shows a 95% success rate in over 700 pediatric patients using tailored enema treatments and monitoring.

Area of Science:

  • Pediatric Gastroenterology
  • Colorectal Surgery
  • Bowel Management

Background:

  • Fecal incontinence is a significant global health issue, often underestimated.
  • Existing literature primarily focuses on adult management, with limited applicability to pediatric cases.
  • Current pediatric treatments for fecal incontinence lack uniform success.

Purpose of the Study:

  • To present a 30-year experience with a comprehensive bowel management program for pediatric fecal incontinence.
  • To evaluate the efficacy and characteristics of a long-term pediatric bowel management strategy.
  • To highlight a successful approach for treating fecal incontinence in children.

Main Methods:

  • Implementation of a bowel management program over 30 years.
  • Inclusion of over 700 pediatric patients with fecal incontinence.
  • Key program components: individual colon characteristic identification, tailored enema selection, and radiological monitoring.

Main Results:

  • Achieved a 95% success rate in treating pediatric fecal incontinence.
  • Demonstrated the effectiveness of personalized colon assessments and enema protocols.
  • Validated the long-term utility of radiological monitoring in the treatment process.

Conclusions:

  • A structured, individualized bowel management program is highly effective for pediatric fecal incontinence.
  • Tailored enema selection and consistent radiological monitoring are crucial for success.
  • This program offers a successful, long-term solution for a challenging pediatric condition.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...